Swiftsure Innovations develops the SwishKit, a device that washes and suctions the oral cavity of mechanically ventilated patients using saline to reduce the risk of ventilator‑acquired pneumonia. The system is designed to clean nasal and oral cavities while minimizing secondary infection risk and improving patient comfort. The company completed its first clinical trials at the Cleveland Clinic last year and is beginning a second clinical study there. Swiftsure has received provincial funding and is committing internal capital to support the next trial as it works toward generating the clinical evidence required for commercial adoption. The company raised $2.3 million in equity funding in 2023. Management says the Cleveland Clinic studies will help validate clinical outcomes, decrease healthcare costs, and enhance patient comfort. Swiftsure Innovations develops and commercializes novel medical devices focused on providing oral-care solutions for critically ill and intubated patients. The company is led by CEO and founder Deanne McCarthy. It raised CAD2.3M in a seed funding round to support commercial activities. The proceeds will enable the company to commercialize SwishKit, an oral care solution for intubated patients. Investors in the round included Pelorus VC (lead), Sandpiper Ventures, the pan-Canadian consortium MEDTEQ+, and several other pre-seed investors. The company is based in Pasadena, Canada. Swiftsure Innovations develops a device for cleaning the mouths and throats of people on ventilators. The company is based in Pasadena, NL. It raised $1.05 million in an oversubscribed seed round. Backers included Threshold Impact, Killick Capital, Pluto Investments, Pelorus Venture Capital and Sandpiper Ventures. The article identifies Sandpiper Ventures as a female-focused venture capital firm.

Total raised

$5M

Funding rounds

3

Latest round

Equity

Latest activity

Oct 2024